| Long name: |
ALEXA FLUOR 488 Conjugated, Apolipoprotein CI/APOC1 Antibody |
| Also known as: |
Anti-Apolipoprotein CI/APOC1 PAb ALEXA FLUOR 488 |
| Category: |
Conjugated Primary Antibodies |
| Conjugated with: |
488, ALEXA FLUOR® |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
Apolipoprotein CI/APOC1 |
| Specificity: |
This is a highly specific antibody against Apolipoprotein CI/APOC1 |
| Modification: |
Unmodified |
| Modification Site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Apolipoprotein CI/APOC1 |
| Gene ID Number: |
341 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Cross-reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen: |
The apolipoprotein C gene family encodes four homologous proteins designated apoC-I to -IV, The human apoC-I gene maps to chromosome 19q13, The human apoC-II gene maps to chromosome 19q13, The human apoC-III gene maps to chromosome 11q23 and encodes a protein that may delay catabolism of triglyceride-rich particles by inhibiting lipoprotein lipase and hepatic lipase, The human apoC-IV gene maps to chromosome 19q13, the enzyme that hydrolyzes triglycerides in plasma and transfers the fatty acids to tissues, which specifically modulate the metabolism of triglyceride-rich lipoproteins, 2 and encodes a 127 amino acid protein that is primarily expressed in the liver, 2 and encodes a 79 amino acid single chain protein that is a necessary cofactor for the activation of lipoprotein lipase, 2 and is expressed primarily in the liver where it is activated when monocytes differentiate into macrophages, Apolipoproteins are protein components of plasma lipoproteins |
| Purification: |
Purified by Protein A |
| Storage conditions: |
50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission: |
499nm/519nm |
| Properties: |
ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 488 has the same range to that of fluorescein isothiocyanate (FITC), Also Alexa Fluor 488 is pH stable, As a result of this photo stability, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, It is distinguished in the FL1 of a FACS-Calibur or FACScan, has a very high photo stability, it has turned into an antibody for fluorescent microscopy and FACS FLOW cytometry, yet the Apolipoprotein CI/APOC1 Antibody, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Gene target: |
Apolipoprotein CI/APOC1 |
| Short name: |
Apolipoprotein CI/APOC1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Label: |
ALEXA FLUOR 488 |
| Alternative name: |
ALEXA FLUOR 488, Apolipoprotein CI/apolipoprotein C-I (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOC1 and IDBG-56839 and ENSG00000130208 and 341, Apoc1 and IDBG-152061 and ENSMUSG00000040564 and 11812, Extracellular, phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005504 and fatty acid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010900 and negative regulation of phosphatidylcholine catabolic process and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0032374 and regulation of cholesterol transport and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034369 and plasma lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034379 and very-low-density lipoprotein particle assembly and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034447 and very-low-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0045717 and negative regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051005 and negative regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0004859 : phospholipase inhibitor activity, this GO :0004859 : phospholipase inhibitor activity and also this GO :0005504 : fatty acid binding and also this GO :0031210 : phosphatidylcholine binding and also this GO :0055102 : lipase inhibitor activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0005504 : fatty acid binding, this GO :0031210 : phosphatidylcholine binding, this GO :0055102 : lipase inhibitor activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, apolipoprotein C-I |
| Identity: |
607 |
| Gene: |
APOC1 |
More about : APOC1 |
| Long gene name: |
apolipoprotein C1 |
| Synonyms gene name: |
apolipoprotein C-I |
| Locus: |
19q13, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
X00570 |
| Entrez gene record: |
341 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000180844 |